|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,165.00 GBX | +1.12% |
|
-1.50% | +18.66% |
| 02-13 | GSK : Receives a Buy rating from Jefferies | ZD |
| 02-13 | Bernstein, Barclays and Deutsche lower Relx | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 118B | |||||
| 929B | |||||
| 587B | |||||
| 409B | |||||
| 374B | |||||
| 320B |
- Stock Market
- Equities
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition